The “cost” of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice

被引:0
作者
John Furler
Justin W S Hii
Danny Liew
Irene Blackberry
James Best
Leonie Segal
Doris Young
机构
[1] The University of Melbourne,Department of General Practice
[2] The University of Melbourne,Melbourne EpiCentre, Royal Melbourne Hospital
[3] The University of Melbourne,Department of Medicine, St Vincent’s Hospital
[4] University of South Australia,Division of Health Sciences
来源
BMC Family Practice | / 14卷
关键词
Type 2 diabetes; Cost; Treatment gap; Treatment burden;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 84 条
[1]  
Davis WA(2006)The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle diabetes study Intern Med J 36 155-161
[2]  
Knuiman MW(2002)Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control Diabetes Care 25 1159-1171
[3]  
Hendrie D(2004)Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes Lancet 363 1589-1597
[4]  
Davis TME(2008)Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 580-591
[5]  
Norris S(2006)Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice Qual Saf Health Care 15 131-135
[6]  
Lau J(2007)Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the quality and outcomes framework for diabetes Diabet Med 24 1436-1441
[7]  
Smith S(2009)A comparison of chronic illness care quality in US and UK family medicine practices prior to pay-for-performance initiatives Fam Pract 26 510-516
[8]  
Schmid C(1987)Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study Clin Chem 33 2267-2271
[9]  
Engelgau M(2009)Drug treatment and cost of cardiovascular disease in Australia Cardiovasc Ther 27 164-172
[10]  
Ismail K(2005)Position statement on lipid management Heart Lung Circ 14 275-291